Facilitates increased assay flexibility and data evaluation options, strengthening functionality in hit confirmation, compound characterisation, early ADME and kinetic-based QSAR
Biacore has announced the launch of a new software upgrade package and two new sensor chips for its Biacore S51 system for lead selection and optimisation applications in drug discovery. The software upgrade will facilitate increased assay flexibility and data evaluation options, strengthening the instrument's functionality in the key areas of hit confirmation, compound characterisation, early ADME and kinetics-based QSAR.
The upgrade will streamline the simultaneous screening of compounds against two targets in a single assay run where different assay methodologies are required.
The new software, Biacore S51 software version 1.2, is free of charge to the current installed base for Biacore S51, and will be the standard for all new systems.
Two new series S sensor chips for use with Biacore S51 will also expand system usage.
Series S sensor chips SA (Streptavidin) and L1 will enable the immobilisation of biotin labelled proteins and lipids and liposomes, respectively.
Biacore S51 was launched in 2001 to reduce critical bottlenecks in drug discovery at stages downstream of high-throughput screening and the addition of the software and additional sensor chips enhances its application and ease of use.
"We are pleased to be able to offer our customers increased utility within current Biacore S51 applications as a result of this software upgrade and the additional sensor chips," commented Julian Abery, vice president and head of the pharmaceutical and biotechnology business unit.
"Biacore continues to develop and enhance functionality of its Biacore S51 and other systems with applications across the life sciences."
